The architecture
Your prescription use intelligence infrastructure.
We don't replace existing systems. We make them significantly more intelligent, from raw prescription data all the way to measurable business outcomes.
Select a layer to trace what feeds it. Click to pin.
Dual-model design
Earlier visibility. Precision monitoring. Actionable and timely intervention.
Mode 1
Continuous Population Risk Management
Broad surveillance. Early identification.
- 1
Population Surveillance
APi90 continuously analyzes prescription-use patterns across the full covered population.
- 2
Risk Identification & Scoring
Multiple risk domains are evaluated into a composite risk score for each member.
- 3
Emerging Risk Detection
Members with escalating or compounding risk are identified before substantial claim costs accumulate.
- 4
Prioritization & Triage
Members are ranked by risk level and complexity to determine who may benefit from closer monitoring.
- 5
Referral for Precision Monitoring
Critical and high-risk members are referred to Mode 2 for targeted monitoring.
Primary value
Reduces the frequency of avoidable high-cost trajectories by discovering risk earlier.
Mode 2
Precision Alert Management
Targeted monitoring. Event-driven intervention.
- 1
Precision Monitoring Enrollment
Critical or high-risk members are selected and 1–2 relevant prescription activities are defined.
- 2
Activity Monitoring
APi90 monitors real-time dispensing activity for the selected events.
- 3
Patient Activity Alert
When a qualifying event occurs, an alert is generated with context about risk and monitored activity.
- 4
Care Management Intervention
The care team reviews the alert, contacts the member, and coordinates clinical or pharmacy support.
- 5
Ongoing Monitoring & Reassessment
Member status is continually reassessed; monitoring is adjusted, continued, or discontinued.
Primary value
Reduces the severity or progression of known or escalating cases through timely, precise intervention.
Shared intelligence foundation
Claims, pharmacy, and clinical data power both modes. Each member has a single, longitudinal risk profile visible across the enterprise.
From insight to action
Turning prescription intelligence into measurable value.
Organizations today spend millions managing healthcare after costs occur. Noventa helps shift that approach toward identifying opportunity before avoidable expense develops.
Clinical Value
- Improved medication adherence
- Better patient stability
- Reduced preventable utilization
- More coordinated care
Financial Value
- Lower pharmacy trend
- Reduced avoidable medical expense
- Better allocation of care management resources
- Improved value from existing healthcare investments
Operational Value
- Prioritized member outreach
- Scalable intervention workflows
- Executive visibility into population risk
- Continuous measurement of outcomes
The future of employer healthcare isn't simply managing claims. It begins by understanding prescription use before claims occur.
TPAs · Care Management · Stop-Loss
The same core and intelligence, shaped to fit your workflow.
TPAs & Self-Insured Employers
Claims tell your clients what already cost them money. Noventa helps reveal which members may be moving toward preventable cost while there is still time to intervene.
Competitive differentiation
What if your TPA could offer employers something most administrators cannot: current prescription-use risk visibility across the covered population?
Earlier visibility
We identify emerging instability such as missed initiation, disrupted refills, regimen complexity and prescribing changes before it becomes obvious in retrospective claims.
Operational value
Noventa converts national prescription activity into a prioritized member queue, the reason each member surfaced, and the next action for the care team.
Would it be useful to examine one employer population and show you what prescription-related risk is currently hidden from the normal claims workflow?
Let's talkCare Management Companies
Your care managers do not need more members on a list. They need to know which member needs attention, why that member surfaced, and when outreach is most likely to matter.
Precision over volume
Noventa turns prescription behavior into a clinically prioritized outreach queue instead of asking nurses to search through another dashboard.
The intervention gap
Roughly one in five new prescriptions is never filled, and many medications that are filled are not used as intended. Those are intervention opportunities claims may reveal too late.
Better timing
The same outreach is not equally valuable every day. We help identify the intervention window when a member's prescription trajectory begins to destabilize.
Could we take one of your current care-management populations and demonstrate how many actionable prescription signals your existing workflow may not be seeing?
Let's talkStop-Loss Carriers
Stop-loss protects the employer financially after a claim reaches the threshold. Noventa strengthens the risk-management process before that threshold is reached.
The upstream opportunity
The carrier usually sees the financial event after the clinical trajectory is established. Prescription behavior can provide earlier evidence that the trajectory is changing.
Frequency and severity
Our continuous surveillance is designed to address claim frequency, while precision alerts give care teams an opportunity to influence severity.
Economic asymmetry
The annual cost of monitoring an employer population can be modest compared with even one avoidable high-cost claim.
Would you be open to testing whether prescription-use intelligence can identify actionable risk earlier within one of your TPA or employer populations?
Let's talkUnderlying engine
Powered by the APi90™ Intelligence Engine
Noventa Rx Intelligence™ is an enterprise platform for prescription-use intelligence, powered by the APi90™ Intelligence Engine that surfaces risk signals from prescription activity.
See Noventa in action.
A short walkthrough of how prescription activity becomes an earlier, actionable view of member risk.